The test, called DARC (Detection of Apoptosing Retinal Cells), involves...
The test, called DARC (Detection of Apoptosing Retinal Cells), involves injecting into the bloodstream (via the arm) a fluorescent dye that attaches to retinal cells, and illuminates those that are undergoing stress or in the process of apoptosis, a form of programmed cell death.
Source: University College London

AI test predicts eye disease years before symptoms

Scientists at University College London (UCL) in collaboration with the Western Eye Hospital, London, have developed an eye test that may predict wet age-related macular degeneration (AMD), a leading cause of severe sight loss, three years before symptoms develop.

The researchers hope their test could be used to identify the disease early enough so that treatment can effectively prevent any vision loss. Wet age-related macular degeneration, also known as macular disease, is the most common cause of permanent and severe sight loss in the UK.

Currently the diagnosis of wet AMD relies on a person developing symptoms, which then leads them to seek advice from a clinician. Initially, someone with wet AMD would notice distortion in their vision, normally interfering with their reading. Very quickly, this can progress to complete central vision loss, which may be extremely troubling to elderly patients who will fear blindness and loss of independence.

Wet AMD involves abnormal growth of blood vessels, which leak fluid into the retina. The introduction of new treatments has led to much improved results for patients, for a disease that over 20 years ago was regarded as untreatable. However, patient outcomes could be even better if treatment was started in the very earliest stages of the disease.

The test, called DARC (Detection of Apoptosing Retinal Cells), involves injecting into the bloodstream (via the arm) a fluorescent dye that attaches to retinal cells, and illuminates those that are undergoing stress or in the process of apoptosis, a form of programmed cell death. The damaged cells appear bright white when viewed in eye examinations – the more damaged cells detected, the higher the DARC count.

One challenge with evaluating eye diseases is that specialists often disagree when viewing the same scans, so the researchers have incorporated an AI algorithm into their method.

“Our new test was able to predict new wet AMD lesions up to 36 months in advance of them occurring."

Francesca Cordeiro

Using the same technology (test) the researchers had previously found that they can detect the earliest signs of glaucoma progression. This new study, which forms part of the same ongoing clinical trial of DARC, assessed 19 of the study participants who had already shown signs of AMD, but not necessarily in both eyes. The AI was newly trained to detect the formation of leaking and new blood vessels, which corresponded with the spots that DARC picked up.

The new analysis found that DARC can uniquely highlight endothelial cells (which line our blood vessels) under stress in the retina. These stressed cells then predict future wet AMD activity with the formation of leaking and new blood vessels seen in patients three years later, using conventional eye scans with Optical Coherence Tomography (OCT).

The researchers say their test could be valuable in detecting new lesions in someone affected by AMD, often in the opposite, unaffected eye, and may eventually be useful for screening people over a certain age or with known risk factors.

Lead researcher Professor Francesca Cordeiro (UCL Institute of Ophthalmology, Imperial College London, and Western Eye Hospital Imperial College Healthcare NHS Trust) said: “Our results are very promising as they show DARC could be used as a biomarker for wet AMD when combined with the AI-aided algorithm. “Our new test was able to predict new wet AMD lesions up to 36 months in advance of them occurring and that is huge – it means that DARC activity can guide a clinician into treating more intensively those patients who are at high risk of new lesions of wet AMD and also be used as a screening tool.”

The study team hope to continue their research with a clinical trial with more participants, and hope to investigate the test in other eye diseases as well.

Chief Executive of eye research charity Fight for Sight, Sherine Krause said: “Our Time to Focus report on the social and economic impact of sight loss stressed the importance of early detection for prevention of sight loss, and so this is a very encouraging development in tackling the leading cause of blindness.”

The study were published in Expert Review of Molecular Diagnostics.

Subscribe to our newsletter

Related articles

AIs detect diabetic eye disease inconsistently

AIs detect diabetic eye disease inconsistently

Although some artificial intelligence software tested reasonably well, only one met the performance of human screeners.

Deep learning enables screening for eye disease

Deep learning enables screening for eye disease

Researchers created a novel deep learning method that makes automated screenings for eye diseases such as diabetic retinopathy more efficient.

AI finds patterns of mutations in tumour images

AI finds patterns of mutations in tumour images

Researchers have developed an AI algorithm that uses computer vision to analyze tissue samples from cancer patients.

AI-based chest X-ray diagnosis tech approved

AI-based chest X-ray diagnosis tech approved

behold.ai has been issued with a CE Mark Class lla certification in the UK and EU for its AI-based technology that can diagnose chest X-rays as ‘normal’.

AI may spot newborns at risk of blinding disease

AI may spot newborns at risk of blinding disease

An AI device may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP).

Retinal screening in diabetes: diagnosis by robot

Retinal screening in diabetes: diagnosis by robot

Physicians have been using automatic digital retinal screening, without assistance from an ophthalmologist, to detect diabetic retinal disease.

AI to sharpen focus of eye testing

AI to sharpen focus of eye testing

Researchers have applied deep learning techniques to develop a more accurate method for analysing images of the back of the eye.

Advanced AI boosts clinical analysis of eye images

Advanced AI boosts clinical analysis of eye images

Based on a convolutional neural network the tool is able to provide results within seconds, thus supporting the doctor with comprehensive image analysis.

AI identifies 'ugly ducklings' to catch skin cancer

AI identifies 'ugly ducklings' to catch skin cancer

Deep learning-based system enables dermatologist-level identification of suspicious skin lesions from smartphone photos, allowing better screening.

Popular articles